Roivant Sciences (NasdaqGS:ROIV) Q3 2026 Earnings call February 06, 2026 08:00 AM ET Company ParticipantsBenjamin Zimmer - CEOMatt Gline - CEOStephanie Lee - Head of Investor RelationsNone - Company RepresentativeConference Call ParticipantsAlexander Thompson - Managing Director, and Senior Equity Research AnalystAshwani Verma - Executive Director of SMID Biotech and Biopharma, and Equity Research AnalystBrian Cheng - Executive Director, and Senior Biotech AnalystCorinne Johnson - Managing Director of Equit ...

Roivant Sciences (NasdaqGS:ROIV) Q3 2026 Earnings call February 06, 2026 08:00 AM ET Company ParticipantsBenjamin Zimmer - CEOMatt Gline - CEOStephanie Lee - Head of Investor RelationsNone - Company RepresentativeConference Call ParticipantsAlexander Thompson - Managing Director, and Senior Equity Research AnalystAshwani Verma - Executive Director of SMID Biotech and Biopharma, and Equity Research AnalystBrian Cheng - Executive Director, and Senior Biotech AnalystCorinne Johnson - Managing Director of Equit ...

Roivant Sciences (NasdaqGS:ROIV) Q3 2026 Earnings call February 06, 2026 08:00 AM ET Speaker6Good day, and thank you for standing by. Welcome to the Roivant Third Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw you ...